Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,44655,1815,2.24 [1.92-2.61],4.381310565240713e-25
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,43928,434,3.77 [2.82-5.03],1.9629431357734785e-19
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,48811,334,1.62 [1.14-2.29],0.0067357296046254
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33738,1590,2.71 [2.29-3.20],2.314437951340605e-31
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48702,225,1.39 [0.91-2.12],0.131468854970677
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,45536,174,3.35 [2.13-5.26],1.4949017924941074e-07
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51207,223,1.35 [0.88-2.07],0.1703328250452057
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51213,151,1.23 [0.73-2.07],0.4436747157822522
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44475,117,2.36 [1.32-4.21],0.0035773582280482
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,49527,237,2.67 [1.80-3.95],9.559529928327524e-07
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49444,154,2.93 [1.82-4.73],9.91485697579692e-06
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51376,136,1.76 [1.02-3.03],0.0411126904312146
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51368,164,1.40 [0.84-2.32],0.1919234828458389
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51356,152,1.39 [0.82-2.35],0.2213137312466334
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,50668,104,1.60 [0.86-2.98],0.1352563083067681
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",48913,834,2.22 [1.79-2.75],4.862718491670977e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48365,286,2.71 [1.90-3.87],4.014958488245209e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48650,571,2.10 [1.62-2.73],2.2124615695648053e-08
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",41161,133,1.04 [0.59-1.83],0.8995748138975324
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41140,112,0.83 [0.43-1.57],0.5607724353953457
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",41555,527,1.18 [0.88-1.58],0.2570469005725161
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",41571,543,1.20 [0.90-1.60],0.2061399914248738
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23302,679,1.29 [0.99-1.69],0.0549439800989492
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18640,235,1.22 [0.80-1.86],0.3597221205461672
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41133,105,3.40 [1.93-6.00],2.330982825717843e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,45854,1597,2.97 [2.53-3.49],2.33252500420416e-40
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",48797,675,1.53 [1.20-1.96],0.0006265115337957
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50446,239,1.40 [0.93-2.11],0.1092877197892764
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51542,222,1.51 [0.99-2.29],0.0563332384359947
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,50972,135,2.84 [1.72-4.69],4.765357306207283e-05
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51553,135,1.40 [0.80-2.43],0.2379207957241418
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Stomach,51648,102,0.99 [0.51-1.91],0.979182889238612
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm,51094,591,1.17 [0.89-1.52],0.260595548687186
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51560,216,1.35 [0.87-2.08],0.1806510430724981
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51568,180,0.98 [0.60-1.59],0.926670350692322
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51443,102,0.72 [0.37-1.39],0.3224209740067268
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma, any site",51447,101,0.69 [0.35-1.33],0.2657621960607784
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi,51277,399,0.93 [0.66-1.30],0.6631052822686778
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,51586,176,0.81 [0.49-1.34],0.4124180068771758
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,51376,367,1.12 [0.80-1.58],0.5148106604175524
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of breast,27806,139,1.10 [0.62-1.96],0.7350044297842664
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Leiomyoma of uterus,27296,996,0.83 [0.67-1.03],0.0981491226244689
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49016,396,3.06 [2.25-4.16],8.781469870909301e-13
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,48368,710,2.52 [1.99-3.19],1.8219421771285668e-14
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,48368,710,2.52 [1.99-3.19],1.8219421771285668e-14
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),44569,934,2.10 [1.70-2.59],3.763282132511458e-12
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50542,139,2.12 [1.23-3.64],0.0067947502027794
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51036,165,1.34 [0.81-2.21],0.2488654929805652
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41683,2365,1.82 [1.58-2.09],3.561050690841913e-17
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,48572,1083,1.89 [1.54-2.31],5.466567783669564e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,46992,271,3.13 [2.17-4.52],1.1840778371608111e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49258,224,2.52 [1.71-3.72],3.244494497781093e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46964,243,3.35 [2.28-4.92],7.498532976991401e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,47835,1114,3.47 [2.88-4.20],3.8119004911122523e-38
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,47800,1079,3.39 [2.80-4.11],9.679993716398362e-36
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,47783,372,1.13 [0.79-1.61],0.5071525215326657
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",47786,368,1.16 [0.81-1.65],0.42613548871266
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41330,2012,1.65 [1.42-1.91],9.417545406738466e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39585,267,1.40 [0.94-2.07],0.0979527072778219
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41173,1855,1.67 [1.42-1.95],1.6475244296764788e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39420,102,1.87 [1.00-3.49],0.0495203615074311
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",39489,171,2.29 [1.43-3.65],0.0005377624908888
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,43662,1304,2.83 [2.38-3.37],1.9309695336525708e-31
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",42814,456,4.54 [3.44-5.98],5.4119119466672e-27
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50836,342,4.19 [3.09-5.67],2.4573109184378023e-20
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50965,248,5.02 [3.55-7.11],8.653723186338102e-20
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,48080,118,3.91 [2.36-6.47],1.0883088013105454e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",51453,118,3.22 [1.95-5.33],5.413576037669801e-06
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",42476,118,4.08 [2.47-6.76],4.4080077552306486e-08
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Alcohol dependence,48104,142,7.63 [4.95-11.75],3.479452825485314e-20
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,47986,115,3.69 [2.22-6.13],4.697601544014921e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42466,108,1.57 [0.86-2.90],0.1448983741648255
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",43010,652,2.63 [2.06-3.35],1.0487794951763881e-14
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression,48428,572,2.38 [1.84-3.08],3.125478591915696e-11
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression or dysthymia,42494,498,2.72 [2.06-3.60],1.4750711215227138e-12
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",42611,253,2.19 [1.48-3.26],0.0001018121019872
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Other anxiety disorders,48708,131,1.90 [1.11-3.26],0.0198491123148357
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,44142,2967,1.68 [1.49-1.90],7.832675902136008e-17
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40070,266,2.69 [1.84-3.93],3.3869564722745425e-07
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51348,210,2.74 [1.79-4.17],2.917329257373609e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,48944,964,1.62 [1.32-1.99],3.445152300493705e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,48285,305,2.90 [2.07-4.07],7.15874684712538e-10
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,48139,159,1.57 [0.94-2.64],0.0871427748660211
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51041,144,1.53 [0.89-2.63],0.1246261198624298
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49972,156,1.30 [0.78-2.16],0.313696701201426
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,48313,333,0.94 [0.66-1.33],0.7154112459180194
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Sleep apnoea,50485,254,0.86 [0.57-1.27],0.4422647953076656
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49300,1340,1.23 [1.03-1.47],0.0250149178994828
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48207,247,1.66 [1.11-2.48],0.0133558146247122
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48733,773,1.11 [0.88-1.41],0.382526467887301
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51037,166,2.21 [1.38-3.52],0.0008918991322862
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,50986,115,2.29 [1.32-3.99],0.0033995154402133
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,50640,247,1.74 [1.16-2.59],0.0067495002273511
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50299,734,1.11 [0.87-1.42],0.3816680386959916
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49991,426,1.16 [0.85-1.59],0.3596675704025169
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49715,150,1.04 [0.61-1.78],0.8756695622944833
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49805,240,1.00 [0.66-1.53],0.9900338379376248
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49720,155,1.13 [0.67-1.92],0.6403474875119979
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,44446,322,1.73 [1.22-2.47],0.002351768986587
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,44923,799,1.55 [1.23-1.95],0.0001719272659513
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49616,439,1.05 [0.77-1.44],0.7453192570329992
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50969,105,2.49 [1.39-4.47],0.0021621024434478
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4394,105,1.07 [0.59-1.93],0.8173381895678418
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",46680,105,2.99 [1.66-5.36],0.0002479189896946
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50269,193,1.31 [0.83-2.08],0.2476200647227795
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50181,105,1.37 [0.73-2.55],0.3232044897092718
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50242,170,1.77 [1.09-2.88],0.0211486940830054
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50533,197,1.50 [0.95-2.36],0.0796177587842516
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,51424,270,1.60 [1.09-2.35],0.016128929892234
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,49895,202,0.82 [0.52-1.29],0.3900810435014967
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36530,6581,1.85 [1.68-2.05],1.5703251549733282e-33
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50352,133,2.15 [1.26-3.67],0.0048955404966063
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38463,4541,1.90 [1.70-2.13],2.9554510500621655e-29
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,38528,4606,1.87 [1.67-2.09],2.98936432184461e-28
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34079,157,1.11 [0.66-1.88],0.6907858633546392
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47208,2406,1.49 [1.30-1.71],8.823083276669724e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,46246,1444,1.61 [1.36-1.91],5.12944357595006e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49524,482,1.74 [1.32-2.30],0.0001008709281206
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50005,963,1.42 [1.16-1.74],0.0007817159963195
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51379,194,1.40 [0.90-2.18],0.1371134918284985
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45403,601,1.30 [1.00-1.69],0.0482182070210177
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,46676,1910,1.43 [1.23-1.67],4.265854806194984e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49972,216,1.54 [1.00-2.37],0.0475123557522336
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50186,458,1.51 [1.13-2.03],0.0058996371720491
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49937,181,1.88 [1.18-2.99],0.0076129608544715
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49939,183,1.91 [1.21-3.03],0.0058292600540902
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34096,174,2.12 [1.30-3.44],0.0025610229565965
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42791,117,1.79 [1.01-3.18],0.0476835987019151
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,42923,249,1.08 [0.71-1.62],0.7278585662126816
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28460,238,0.99 [0.64-1.54],0.968775345482291
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,29104,882,1.83 [1.45-2.32],3.858012696427893e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arrhythmias,42810,136,1.26 [0.73-2.19],0.4075807274118902
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,42858,184,1.61 [1.01-2.56],0.0440794509106689
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49479,412,1.93 [1.42-2.61],2.3542239017073e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49818,312,1.79 [1.26-2.54],0.0011382923087621
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49888,262,1.73 [1.18-2.54],0.0047399601998116
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50047,231,1.78 [1.19-2.67],0.0052197636157185
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49255,160,2.01 [1.24-3.24],0.0043585278225169
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49354,259,2.48 [1.72-3.57],1.231332226100686e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48664,284,1.54 [1.06-2.24],0.0251791761582444
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48623,243,1.77 [1.19-2.65],0.0051992565409434
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51203,233,1.69 [1.13-2.54],0.0113483635818626
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Varicose veins,49334,954,0.97 [0.78-1.20],0.7595414743167888
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,49183,173,1.71 [1.05-2.78],0.0295522061412738
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41157,4132,1.88 [1.69-2.09],6.6690564626368414e-31
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51258,217,1.84 [1.20-2.80],0.0049970795759793
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,47846,452,2.13 [1.59-2.85],4.1790949310461066e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",47788,394,2.25 [1.65-3.07],3.220478015784379e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,49741,507,1.76 [1.34-2.32],6.002478455966544e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,49730,496,1.78 [1.35-2.36],4.75493443412992e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50018,1222,1.18 [0.98-1.42],0.0793293497422452
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic sinusitis,48984,188,1.31 [0.82-2.11],0.2562914223226039
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Nasal polyp,49044,248,0.77 [0.51-1.17],0.2290860093990412
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49578,782,1.35 [1.07-1.70],0.0100922039252786
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Deviated nasal septum,49162,366,1.15 [0.82-1.61],0.4214173837663082
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23728,126,2.68 [1.53-4.71],0.0005904479143559
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,46123,2025,1.78 [1.54-2.06],6.3051036423125465e-15
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,49254,350,2.24 [1.62-3.09],1.1457448914533066e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49307,403,2.60 [1.93-3.51],2.94375804400061e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",49307,403,2.60 [1.93-3.51],2.94375804400061e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",48161,1673,1.43 [1.22-1.68],1.192834789507177e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Asthma,36838,1673,1.75 [1.48-2.06],3.6986293938457225e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",36298,1673,1.77 [1.50-2.09],1.0531794023685927e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",36814,1649,1.77 [1.50-2.09],1.5242091675912435e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50884,177,3.00 [1.94-4.65],8.042133743591508e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,48655,136,3.82 [2.34-6.24],8.826550737053206e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",51043,136,3.59 [2.22-5.81],2.075951411491529e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48642,123,4.04 [2.42-6.73],8.70832081530196e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,47442,222,2.68 [1.78-4.03],2.089805131675106e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,47690,470,2.34 [1.76-3.11],4.7710607827157705e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,49082,216,1.96 [1.29-2.97],0.0015437171035986
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35102,11695,1.81 [1.67-1.95],2.684341817388682e-50
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50576,848,1.21 [0.97-1.51],0.0988775468878405
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51574,184,1.00 [0.61-1.63],0.9986595704559598
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impacted teeth,51582,171,1.15 [0.69-1.90],0.5974845328266656
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,49946,218,1.18 [0.76-1.82],0.4579126197282865
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49929,201,1.13 [0.71-1.79],0.6009453123773951
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51555,203,0.95 [0.59-1.51],0.8199807419156346
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49926,198,1.68 [1.07-2.64],0.0242070666428752
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49385,155,1.17 [0.69-1.96],0.5624533234781113
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51411,104,0.91 [0.48-1.72],0.7646584230208657
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39240,545,2.11 [1.61-2.76],5.7682159634303535e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",43020,4325,1.88 [1.69-2.09],3.217453666571049e-32
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,39370,675,2.31 [1.81-2.95],1.5676266506176795e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,40085,1390,1.76 [1.48-2.10],3.583191672929742e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38849,154,2.27 [1.37-3.75],0.001441292028417
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39101,406,2.40 [1.76-3.27],3.4122857136202194e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38810,115,3.01 [1.71-5.28],0.0001286102879807
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,39003,308,2.08 [1.45-2.98],6.447607360547599e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,38941,246,2.21 [1.50-3.27],6.982478788935996e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51363,169,1.62 [1.01-2.59],0.0438641839026594
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,38942,247,2.01 [1.34-3.00],0.000663548707442
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),40331,1636,2.22 [1.89-2.60],1.5746860768178274e-22
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of appendix,51323,255,1.26 [0.84-1.90],0.2608900872779399
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Functional dyspepsia,39568,873,1.46 [1.17-1.84],0.0010142746924646
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39040,345,2.38 [1.69-3.34],6.551207328969272e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51313,311,1.86 [1.31-2.65],0.0005357029616737
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute appendicitis,51274,206,1.20 [0.76-1.90],0.4242935471142001
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,45183,3266,1.44 [1.28-1.62],1.2907332032930082e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Inguinal hernia,43122,1205,0.96 [0.79-1.17],0.6971405089087064
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Umbilical hernia,42175,258,1.26 [0.85-1.87],0.2447833017009232
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,42123,206,1.82 [1.18-2.81],0.0071922650297849
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,43645,1728,1.98 [1.70-2.32],6.641303181233466e-18
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49675,1532,1.99 [1.69-2.35],1.5590179530801742e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,40394,4028,1.60 [1.44-1.79],1.6667065080621868e-17
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50948,120,2.91 [1.69-5.01],0.0001174386201572
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",51498,165,2.47 [1.54-3.97],0.0001884347563926
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,48308,165,2.57 [1.60-4.14],9.714429976649487e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48269,126,2.23 [1.29-3.87],0.0042647774005315
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",51362,278,1.77 [1.21-2.59],0.0029775149791669
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcerative colitis,48421,278,1.85 [1.27-2.71],0.0014809732305504
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48393,250,2.34 [1.58-3.47],2.102712032749377e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49383,1240,2.09 [1.74-2.50],1.314583744143483e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49369,1226,2.04 [1.70-2.45],1.586739997896995e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36569,203,1.78 [1.14-2.78],0.0117802586938096
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal stricture,50703,203,1.61 [1.03-2.51],0.0369165001182478
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36500,134,1.71 [0.99-2.96],0.0549730189573239
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,37584,1218,1.56 [1.29-1.89],3.914887363484808e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36699,333,1.78 [1.24-2.54],0.0015725127230137
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,36940,574,2.31 [1.77-3.00],6.303505243159936e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,48340,517,2.11 [1.60-2.78],1.347050238616357e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50719,179,1.67 [1.04-2.68],0.0344047907679145
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36651,285,1.99 [1.38-2.89],0.0002700374624134
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36511,145,1.66 [0.99-2.79],0.054624219106872
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38136,1770,1.45 [1.24-1.69],4.534539905564679e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,36918,552,1.54 [1.17-2.03],0.0018689651932148
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50691,151,1.34 [0.79-2.28],0.2722993645491585
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,49994,250,9.26 [6.68-12.83],1.053971708937931e-40
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,49882,138,6.50 [4.10-10.30],1.6589233971713337e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",48875,1264,2.08 [1.73-2.49],2.869129375894148e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,48624,1013,1.83 [1.49-2.25],6.210290313938939e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,47812,201,2.35 [1.52-3.65],0.0001309236699784
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47713,102,5.07 [2.92-8.80],7.508585093225165e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,47748,137,2.68 [1.61-4.46],0.0001396990478732
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),51278,137,2.54 [1.53-4.21],0.000318483361346
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,48837,628,2.44 [1.91-3.11],7.205749000695563e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48349,140,3.57 [2.16-5.90],6.780099390026972e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,48323,114,3.86 [2.24-6.67],1.2265886276263444e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48311,102,2.63 [1.46-4.76],0.0013568323146392
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,48607,398,2.03 [1.50-2.76],5.966426503386913e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,48593,384,1.98 [1.45-2.71],1.781609527475754e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,45273,3123,1.43 [1.27-1.62],4.8637438692044025e-09
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50721,207,1.50 [0.97-2.34],0.070579569068216
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50786,915,1.15 [0.93-1.43],0.200598582402637
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,48419,1163,1.51 [1.25-1.83],2.523609810595437e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49781,790,1.54 [1.23-1.93],0.0001704628750071
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49166,175,1.80 [1.14-2.87],0.0125368585870641
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49498,507,1.78 [1.35-2.35],4.46245916847683e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51072,183,1.97 [1.25-3.11],0.0035751472348752
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51030,141,2.53 [1.53-4.18],0.0002871250470507
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50997,108,2.67 [1.51-4.72],0.0007251882630116
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51034,114,1.20 [0.65-2.22],0.5566928503472686
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51029,109,1.25 [0.67-2.34],0.4759107927182789
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49987,116,1.36 [0.75-2.46],0.306980350240591
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50600,729,1.05 [0.83-1.34],0.6799305162512159
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47440,184,0.81 [0.50-1.32],0.4004943428821549
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47457,201,1.90 [1.20-2.99],0.0059125871711088
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47409,153,1.72 [1.02-2.91],0.0419884756041835
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47702,446,1.38 [1.02-1.88],0.0399209762856337
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47654,398,1.39 [1.01-1.93],0.0459765743037841
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37145,7993,1.48 [1.36-1.62],1.6006703951393525e-19
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40405,4646,1.31 [1.18-1.46],3.212756449380454e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46537,2419,1.57 [1.38-1.80],2.9926429220664303e-11
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36062,303,4.62 [3.29-6.50],1.5598786632890917e-18
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36702,943,2.46 [2.00-3.02],1.814618061075492e-17
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50781,291,4.12 [2.94-5.78],2.031962820081156e-16
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50803,263,4.51 [3.18-6.40],2.9867259838859345e-17
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,38057,2298,1.19 [1.03-1.38],0.0180964587269178
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",43237,2298,1.13 [0.98-1.31],0.0871560210265703
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35901,142,1.47 [0.86-2.50],0.1603425954820115
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50464,138,1.56 [0.92-2.63],0.0967486394036828
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,36213,454,1.73 [1.28-2.35],0.0003733767947874
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,35902,143,1.41 [0.82-2.43],0.2175859613654686
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,36322,563,0.81 [0.61-1.08],0.1569728684559298
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51313,277,0.93 [0.63-1.38],0.7170146900216625
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,36813,1054,1.20 [0.97-1.47],0.0874560084162824
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,36554,795,1.50 [1.19-1.90],0.0006428015318986
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,38342,2583,1.18 [1.03-1.35],0.0165206734717055
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35890,131,1.07 [0.59-1.94],0.8128458556219187
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36233,474,1.25 [0.91-1.71],0.1741321864410089
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35871,112,0.96 [0.50-1.81],0.8917108653536586
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35881,122,0.85 [0.46-1.58],0.6085144990740292
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36726,967,0.89 [0.72-1.10],0.2896083222435893
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36594,835,0.83 [0.66-1.05],0.1154635185016428
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39954,558,1.84 [1.40-2.41],1.0300976906645904e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50510,261,4.46 [3.09-6.44],1.3076762186884157e-15
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50363,114,4.72 [2.74-8.12],2.1009273775069955e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44622,127,0.91 [0.50-1.63],0.7443801088809348
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,45090,595,1.55 [1.19-2.02],0.0010913688456965
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,46358,1863,1.51 [1.30-1.76],9.187164765358737e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,44876,381,1.64 [1.18-2.28],0.0032020394783223
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44670,175,0.95 [0.58-1.55],0.8314691896535709
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",45963,1468,1.53 [1.29-1.81],1.080716024158633e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44599,104,1.49 [0.80-2.79],0.2116899882494934
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44966,471,1.05 [0.78-1.43],0.7368339836154507
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44698,203,1.40 [0.89-2.21],0.1492331381699674
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44654,159,1.60 [0.96-2.65],0.0712935330282109
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44776,281,1.45 [0.98-2.13],0.0597745082181237
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44624,129,2.84 [1.66-4.85],0.0001321841661848
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45106,611,2.02 [1.57-2.61],6.39789973682382e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44745,627,1.45 [1.12-1.88],0.0052275672654565
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44253,135,1.93 [1.13-3.30],0.0162248588084714
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44293,175,2.09 [1.30-3.36],0.0022584541063167
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44324,206,0.96 [0.60-1.52],0.8472882047767787
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44217,99,1.21 [0.63-2.31],0.5667331367119038
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44353,235,2.15 [1.45-3.21],0.0001556991761564
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44326,208,1.97 [1.29-3.01],0.0017568686214279
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44644,526,1.45 [1.10-1.92],0.0093204450924422
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44230,112,1.62 [0.89-2.94],0.1134930080981354
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44270,152,1.54 [0.92-2.55],0.0977386613404664
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44366,248,1.59 [1.06-2.38],0.0246544984241895
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44241,123,1.54 [0.86-2.75],0.1476066113339906
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45007,889,1.68 [1.36-2.09],2.1719416361324605e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44451,333,1.52 [1.07-2.15],0.0198435238252475
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44595,477,1.58 [1.18-2.11],0.0022973395914586
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,47822,340,2.04 [1.44-2.87],5.0223038360563664e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,48259,777,1.68 [1.33-2.11],1.2650574473151552e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47581,99,2.39 [1.30-4.37],0.0049431159739868
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47599,117,0.90 [0.49-1.68],0.750525591114662
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47685,203,1.15 [0.73-1.83],0.5449444344772973
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,40934,8572,1.25 [1.15-1.35],2.3802295846761118e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20479,1290,1.09 [0.91-1.31],0.3633406088474487
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,46326,508,1.42 [1.07-1.89],0.015194762495894
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45955,137,1.10 [0.63-1.91],0.7412392094780362
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,46530,109,1.21 [0.66-2.22],0.5346438809228798
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,46558,137,1.85 [1.09-3.14],0.0223167641573443
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46556,135,1.65 [0.96-2.82],0.0685254205743212
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50887,492,1.43 [1.08-1.90],0.0137291415735491
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50724,146,1.35 [0.80-2.27],0.2624499124752739
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50751,356,1.38 [0.99-1.93],0.0577282011455152
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50566,171,1.24 [0.77-2.01],0.3799693886013662
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,47132,2099,1.37 [1.19-1.59],2.1239986933548023e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,45231,198,1.40 [0.88-2.23],0.1598277544574208
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45197,164,1.74 [1.06-2.86],0.029411287080702
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45583,550,1.26 [0.95-1.66],0.103877211456539
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45264,231,1.31 [0.85-1.99],0.2175041339468182
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,46396,1363,1.54 [1.29-1.85],2.3160761810290423e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19761,572,1.01 [0.77-1.33],0.9438024646747764
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19296,107,0.63 [0.33-1.17],0.1442480707445099
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydrocele,19292,103,1.37 [0.75-2.52],0.307403498550946
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19354,165,1.39 [0.86-2.25],0.1793842691993294
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19350,161,0.82 [0.50-1.36],0.4440057447779151
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19407,218,1.22 [0.80-1.87],0.3555202874124753
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27546,483,0.95 [0.70-1.30],0.751643055397869
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27212,149,0.76 [0.44-1.33],0.3391173637384098
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27235,172,0.98 [0.59-1.65],0.951960602738556
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27177,114,1.30 [0.70-2.43],0.4107046060554824
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27484,559,0.82 [0.61-1.09],0.1705145815723026
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27058,133,0.70 [0.39-1.26],0.2385408124039142
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27176,251,0.99 [0.65-1.52],0.9764898319453093
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25388,4627,1.00 [0.90-1.12],0.9856384772038966
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Endometriosis,21122,361,0.96 [0.67-1.38],0.8352576542850543
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20859,98,1.10 [0.56-2.19],0.7813520579709045
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20924,163,0.88 [0.52-1.48],0.6180748619338727
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21557,796,1.21 [0.95-1.54],0.1231841376121124
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21173,412,1.14 [0.81-1.59],0.4476362103516179
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21733,972,0.69 [0.55-0.86],0.0010283675124585
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21082,321,0.59 [0.41-0.86],0.0055105019810036
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21206,445,0.92 [0.67-1.28],0.6298590719499106
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20862,101,0.74 [0.38-1.43],0.3656769858985643
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20950,189,1.12 [0.68-1.84],0.6467017729392406
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27823,267,1.09 [0.72-1.65],0.6921640478391029
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27835,254,1.17 [0.76-1.79],0.482457902666167
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27860,141,1.05 [0.59-1.87],0.8631716385370729
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27849,154,1.00 [0.58-1.73],0.9964517595829132
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20908,147,1.58 [0.92-2.72],0.1007596648471403
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20878,117,0.90 [0.48-1.68],0.7470518915140467
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20906,145,0.72 [0.41-1.26],0.2470368785253983
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Irregular menses,27752,472,1.14 [0.84-1.56],0.399014739696398
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22119,1358,1.14 [0.94-1.38],0.1693918417321485
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21648,887,1.11 [0.88-1.40],0.3657227019563319
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27840,197,0.96 [0.60-1.56],0.8842592137895358
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21231,470,1.17 [0.85-1.60],0.3269097553168205
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21093,332,0.97 [0.67-1.40],0.8555639258187833
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21670,909,0.96 [0.76-1.20],0.7105017050281843
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female infertility,20877,116,0.62 [0.34-1.12],0.1162404726674609
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20870,109,0.64 [0.35-1.19],0.1571329822799346
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27858,887,0.84 [0.65-1.09],0.1854933499547874
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27862,1206,0.85 [0.68-1.07],0.1644470275904644
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27859,482,0.73 [0.53-1.01],0.0539572063268312
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27515,138,0.74 [0.41-1.34],0.3127471108666636
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27571,194,0.74 [0.46-1.20],0.2258509000417825
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27544,167,0.55 [0.34-0.91],0.0188063621994511
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27876,166,1.27 [0.74-2.20],0.3820836595551355
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27878,163,1.28 [0.74-2.22],0.372119704014196
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27874,419,0.86 [0.61-1.21],0.3892757620051496
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27581,126,0.84 [0.45-1.55],0.5743426907636529
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27685,230,1.07 [0.68-1.71],0.7603528141429152
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27121,150,0.82 [0.46-1.44],0.4801288155000439
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27174,203,0.76 [0.47-1.23],0.2716026865843869
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27222,251,1.19 [0.76-1.87],0.4364996797003999
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27122,151,0.65 [0.38-1.11],0.1156951389412096
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27110,139,0.53 [0.31-0.89],0.0174261807689824
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27124,153,0.48 [0.29-0.79],0.0042857229692497
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26888,232,0.64 [0.40-1.02],0.0578209633589618
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27094,438,0.84 [0.59-1.20],0.3387262867192022
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27328,672,0.88 [0.65-1.19],0.4012797463708047
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27880,172,0.83 [0.49-1.40],0.4758122431835868
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26411,131,0.77 [0.42-1.44],0.4196797378119076
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26759,103,0.93 [0.46-1.86],0.8283532740997832
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27887,346,0.67 [0.47-0.98],0.0371548908697963
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27804,263,0.66 [0.43-1.00],0.0507469534008591
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27874,255,1.01 [0.65-1.56],0.9749824987794878
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27865,246,1.03 [0.66-1.61],0.9069377810221426
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50834,123,0.84 [0.47-1.50],0.5482676451963757
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,46497,1201,1.43 [1.18-1.73],0.0002445723373708
